Oxford Photovoltaics has secured an initial $10.7m in series C capital from unnamed investors as it gears up for commercialisation.

Gruner + Jahr and Ringier have taken part in the DIY crafting platform's series B round alongside existing shareholders OZ Verlag and High-Tech Gruenderfonds.

Bayer invested $35m in the Switzerland-based gene editing company but it floated below its range and lowered the number of shares in the offering.

The automotive components producer will invest in technologically relevant companies at early and late-stage through the newly formed Zukunft Ventures unit.

Existing investor AstraZeneca was among the investors that took part in the placement, which lifted the cancer drug developer's overall financing to $255m.